We’re excited to announce that BrosMed team will attend AICT-AsiaPCR 2023 – the first in person Interventional Cardiology congress in the Asia Pacific Region since 2019, from Sep. 21st to 22nd in Singapore. As a company committed to improving clinic outcomes through innovative medical devices, we look forward to connecting with industry peers, experts, clinicians, and researchers at this premier conference.
Engage with industry peers and immerse yourself in global research insights. We’ll be showcasing our latest cardiovascular products and solutions, and we’re eager to learn from and collaborate with you.
We’re excitedly gearing up to showcase our advanced toolkit for complex coronary interventions:
- POT™ PTCA NC Balloon Dilatation Catheter : Dedicated Balloon for POT and DOT Technique
- Alveo™ HP CTO Balloon Dilatation Catheter : Smallest ø 0.75mm CTO Balloon in the world
- Wedge™ NC Scoring Balloon Dilatation Catheter : Safe and controlled lesion preparation
- Pronavi™ Microcatheter : Two low-profile options: 1.7F &1.9F, 135cm length for antegrade, 150cm & 162cm length for retrograde
Jot down September 21-22 and come ready to dive into enriching conversations with our teams. Please contact us via email: email@example.com if you are planning on participating in this leading congress. We are delighted to meet you there and get inspiration of technology and innovation from each other. See you there!
About BrosMed Medical
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers(Labs), two manufacturing centers around China, Europe and Asian Pacific. BrosMed has more than 40 product series and 360+ products registration certificates in worldwide.